Related Experiment Video
Updated: Jul 6, 2026

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025
Sanfilippo syndrome: a mini-review
M J Valstar1, G J G Ruijter, O P van Diggelen
1Department of Pediatrics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Mucopolysaccharidosis type III (MPS III, Sanfilippo syndrome) is a genetic disorder impacting heparan sulfate degradation. Diagnosis involves urine tests and enzyme assays, with no current cure but promising future therapies.
Area of Science:
- Biochemistry
- Genetics
- Lysosomal Storage Disorders
Background:
- Mucopolysaccharidosis type III (MPS III), or Sanfilippo syndrome, is an inherited metabolic disorder.
- It results from deficiencies in enzymes crucial for breaking down heparan sulfate in lysosomes.
- Four subtypes (MPS IIIA, B, C, D) exist, each linked to a specific enzyme deficiency.
Purpose of the Study:
- To provide a comprehensive overview of Mucopolysaccharidosis type III.
- To detail diagnostic approaches and clinical manifestations.
- To discuss the current therapeutic landscape and future prospects.
Main Methods:
- Diagnosis relies on detecting elevated heparan sulfate levels in urine.
- Enzymatic assays in leukocytes or fibroblasts confirm the diagnosis and differentiate subtypes.
- Clinical progression is categorized into three distinct phases.
Main Results:
- MPS III presents with developmental delay, severe behavioral issues, and progressive cognitive decline.
- Motor deficits, swallowing difficulties, and spasticity characterize later stages.
- Patient lifespan typically extends into the second or third decade.
Conclusions:
- While no definitive treatment exists, ongoing research offers hope for interventions.
- Therapeutic strategies aim to halt or reverse the neurocognitive and behavioral deterioration.
- Understanding MPS III is critical for developing effective management and potential cures.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
10:47Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs)
Published on: March 2, 2018
Related Concept Videos
Huntington Disease l: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Lysosomal Hydrolases
Microtubules in Signaling
Parkinson Disease ll: Pathophysiology
EPS and iPS Cells in Disease Research